<code id='7BA484B91B'></code><style id='7BA484B91B'></style>
    • <acronym id='7BA484B91B'></acronym>
      <center id='7BA484B91B'><center id='7BA484B91B'><tfoot id='7BA484B91B'></tfoot></center><abbr id='7BA484B91B'><dir id='7BA484B91B'><tfoot id='7BA484B91B'></tfoot><noframes id='7BA484B91B'>

    • <optgroup id='7BA484B91B'><strike id='7BA484B91B'><sup id='7BA484B91B'></sup></strike><code id='7BA484B91B'></code></optgroup>
        1. <b id='7BA484B91B'><label id='7BA484B91B'><select id='7BA484B91B'><dt id='7BA484B91B'><span id='7BA484B91B'></span></dt></select></label></b><u id='7BA484B91B'></u>
          <i id='7BA484B91B'><strike id='7BA484B91B'><tt id='7BA484B91B'><pre id='7BA484B91B'></pre></tt></strike></i>

          knowledge

          knowledge

          author:focus    Page View:32562
          A person stands in front of a Google office building -- coverage from STAT
          NOAH SEELAM/AFP via Getty Images

          Google’s generative AI system proved it can answer medical exam questions. But now the company is attempting a bigger leap — infusing its model with medical images such as X-rays and mammograms to help it communicate with doctors about data routinely used in patient care.

          The effort, unveiled Wednesday, marks the beginning of a quest to make generative AI a more dynamic tool in medicine. While prior iterations of AI could either analyze images, or respond to questions, the company’s new model, known as Med-Palm 2, aims to put those capabilities together in a single system.

          advertisement

          “Until this year, this was not on the table,” said Greg Corrado, a senior research scientist at Google. “Now you can build a system — and this is amazing to me, honestly, I did not expect this to happen now — but you can build a system where you give it an image, it writes a report, and then you can ask it follow-up questions.”

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Diverse clinical trials: Why aren’t we there yet?
          Diverse clinical trials: Why aren’t we there yet?

          KeishaOkaforforSTATClinicaltrialsarecriticaltoadvancinglifesavingmedicationsandtreatments.ButtheU.S.

          read more
          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more

          What to make of Biden’s latest efforts on cancer research

          PresidentBidenspeaksontheCancerMoonshotinitiativeattheJohnF.KennedyLibraryin2022.EvanVucci/APWASHING